Product Information
PAROXETINE HCL 20 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0611 per EA under NDC 69584067250. Its NADAC has been published 186 times since Mar 15, 2023.
FDA first approved this application on Jun 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584067250
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076968FDA Approved
6/21/2010
TE Code
AB
On Market Since
11/14/2022
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 20 MG TABLET has been published 186 times since Mar 15, 2023, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0611 per EA |
|---|---|
| All-time high | $0.0871 (Jan 10, 2024) |
| All-time low | $0.0575 (Jul 17, 2024) |
| 52-week high | $0.0740 |
| 52-week low | $0.0611 |
| Median price | $0.0712 |
| Average price | $0.0712 |
| Largest weekly change | +26.5% (Dec 20, 2023) |
| Weeks tracked | 186 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oxford Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
paroxetine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 20 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0611 per EA (NDC 69584067250), effective Sep 30, 2026.
How has the price of PAROXETINE HCL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 20 MG TABLET has declined 28.5%. It has been tracked across 186 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 20 MG TABLET?
Since Mar 15, 2023, the NADAC for PAROXETINE HCL 20 MG TABLET has ranged from a low of $0.0575 (Jul 17, 2024) to a high of $0.0871 (Jan 10, 2024), with a median of $0.0712 per EA.
Are there cheaper alternatives to PAROXETINE HCL 20 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE HCL 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE HCL 20 MG TABLET?
PAROXETINE HCL 20 MG TABLET (NDC 69584067250) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.